Brighi N.; Panzuto F.; Modica R.; Gelsomino F.; Albertelli M.; Pusceddu S.; Massironi S.; Lamberti G.; Rinzivillo M.; Faggiano A.; Spallanzani A.; Ferone D.; Prinzi N.; Rossi R.E.; Annibale B.; Colao A.M.; Campana D., Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study, «THE ONCOLOGIST», 2020, 25, pp. 259 - 265 [articolo]
Lamberti G.; Spurr L.F.; Li Y.; Ricciuti B.; Recondo G.; Umeton R.; Nishino M.; Sholl L.M.; Meyerson M.L.; Cherniack A.D.; Awad M.M., Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer, «ANNALS OF ONCOLOGY», 2020, 31, pp. 807 - 814 [articolo]
Parisi C.; Lamberti G.; Zompatori M.; Gelsomino F.; Salvagni S.; Sperandi F.; Ardizzoni A., Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer, «JOURNAL FOR IMMUNOTHERAPY OF CANCER», 2020, 8, pp. 1 - 3 [articolo]Open Access
Panzuto F.; Massironi S.; Partelli S.; Campana D.; Rinzivillo M.; Invernizzi P.; Andreasi V.; Lamberti G.; Falconi M., Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management, «SURGICAL ONCOLOGY», 2020, 35, pp. 141 - 148 [articolo]
Abu-Sbeih H.; Faleck D.M.; Ricciuti B.; Mendelsohn R.B.; Naqash A.R.; Cohen J.V.; Sellers M.C.; Balaji A.; Ben-Betzalel G.; Hajir I.; Zhang J.; Awad M.M.; Leonardi G.C.; Johnson D.B.; Pinato D.J.; Owen D.H.; Weiss S.A.; Lamberti G.; Lythgoe M.P.; Manuzzi L.; Arnold C.; Qiao W.; Naidoo J.; Markel G.; Powell N.; Yeung S.-C.J.; Sharon E.; Dougan M.; Wang Y., Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease, «JOURNAL OF CLINICAL ONCOLOGY», 2020, 38, pp. 576 - 583 [articolo]Open Access
Tateo V.; Manuzzi L.; De Giglio A.; Parisi C.; Lamberti G.; Campana D.; Pantaleo M.A., Immunobiology of thymic epithelial tumors: Implications for immunotherapy with immune checkpoint inhibitors, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2020, 21, Article number: 9056, pp. 1 - 16 [articolo]Open Access
Ricciuti, B.; Recondo, G.; Spurr, L. F.; Li, Y. Y.; Lamberti, G.; Venkatraman, D.; Umeton, R.; Cherniack, A. D.; Nishino, M.; Sholl, L. M.; Shapiro, G. I.; Awad, M. M.; Cheng, M. L., Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non–Small Cell Lung Cancer, «CLINICAL CANCER RESEARCH», 2020, 26, pp. 4135 - 4142 [articolo]
Maggio I.; Manuzzi L.; Lamberti G.; Ricci A.D.; Tober N.; Campana D., Landscape and future perspectives of immunotherapy in neuroendocrine neoplasia, «CANCERS», 2020, 12, pp. 832 - 856 [articolo]Open Access
Recondo G.; Bahcall M.; Spurr L.F.; Che J.; Ricciuti B.; Leonardi G.C.; Lo Y.-C.; Li Y.Y.; Lamberti G.; Nguyen T.; Milan M.S.D.; Venkatraman D.; Umeton R.; Paweletz C.P.; Albayrak A.; Cherniack A.D.; Price K.S.; Fairclough S.R.; Nishino M.; Sholl L.M.; Oxnard G.R.; Janne P.A.; Awad M.M., Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC, «CLINICAL CANCER RESEARCH», 2020, 26, pp. 2615 - 2625 [articolo]
Brighi, Nicole; La Rosa, Stefano; Rossi, Giulio; Grillo, Federica; Pusceddu, Sara; Rinzivillo, Maria; Spada, Francesca; Tafuto, Salvatore; Massironi, Sara; Faggiano, Antongiulio; Antonuzzo, Lorenzo; Santini, Donatella; Sessa, Fausto; Maragliano, Roberta; Gelsomino, Fabio; Albertelli, Manuela; Vernieri, Claudio; Panzuto, Francesco; Fazio, Nicola; De Divitiis, Chiara; Lamberti, Giuseppe; Colao, Annamaria; Fave, Gianfranco Delle; Campana, Davide, Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study, «ANNALS OF SURGERY», 2020, 271, pp. 527 - 533 [articolo]
Lamberti G.; Gelsomino F.; Brocchi S.; Poerio A.; Melotti B.; Sperandi F.; Gargiulo M.; Borghi C.; Fiorentino M.; Ardizzoni A., New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2020, 12, pp. 1 - 6 [articolo]Open Access
Lamberti, G.; Faggiano, A.; Brighi, N.; Tafuto, S.; Ibrahim, T.; Brizzi, M. P.; Pusceddu, S.; Albertelli, M.; Massironi, S.; Panzuto, F.; Badalamenti, G.; Riccardi, F.; Butturini, G.; Gelsomino, F.; De Divitiis, C.; Modica, R.; Bongiovanni, A.; La Salvia, A.; Torchio, M.; Colao, A.; Ferone, D.; Campana, D., Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor, «THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM», 2020, 105, pp. 194 - 200 [articolo]
Gelsomino, F.; Di Federico, A.; Filippini, D. M.; Dall'Olio, F. G.; Lamberti, G.; Sperandi, F.; Balacchi, C.; Brocchi, S.; Ardizzoni, A., Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report, «CLINICAL LUNG CANCER», 2020, 21, pp. E45 - E48 [articolo]
Lamberti, Giuseppe; Brizzi, Maria Pia; Pusceddu, Sara; Gelsomino, Fabio; Di Meglio, Giovanni; Massari, Francesco; Badalamenti, Giuseppe; Riccardi, Ferdinando; Ibrahim, Toni; Ciccarese, Chiara; Buti, Sebastiano; Carnaghi, Carlo; Prinzi, Natalie; Panzuto, Francesco; Campana, Davide, Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter Analysis, «JOURNAL OF CLINICAL MEDICINE», 2020, 9, Article number: 1351, pp. 1 - 12 [articolo]Open Access
Gelsomino F.; Tiseo M.; Barbieri F.; Riccardi F.; Cavanna L.; Frassoldati A.; Delmonte A.; Longo L.; Dazzi C.; Cinieri S.; Colantonio I.; Sperandi F.; Lamberti G.; Brocchi S.; Tofani L.; Boni L.; Ardizzoni A., Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL), «BRITISH JOURNAL OF CANCER», 2020, 123, pp. 26 - 32 [articolo]Open Access
